Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound Monitoring in mRCC
NCT04508725Completed
- Sponsor
- Stanford University
- Start
- Dec 2020
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Open-label trial in metastatic renal cell carcinoma (mRCC) (2 arms), sponsored by Stanford University. Primary endpoints: Initial Objective Response- First Participation at 12 weeks and Initial Objective Response- Second Participation at 12 weeks. Started Dec 2020; status: completed.
02
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT04508725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04508725.